Efficacy and safety of consensus interferon (CIFN) plus ribavirin (RBV) for naive patients with chronic hepatitis C (CHC): Final report of a pilot study
G. Fattovich, A. Tagger(University of Milan), C. Paternoster, C. Scattolini, A. Miracolo(University of Bologna), M. Pantalena, Caterina Rizzo(University of Pisa), S. Suppressa(Azienda Usl 8 Arezzo), P. Benedetti(Ospedale San Bortolo), P. Pignalosa, P. Rovere(Azienda Ospedaliera Ospedale Civile di Legnano), Antonio Carlotto, I. Zagni, Pedro Marques da Costa(University of Lisbon), Angelo Rossini(Centro Universitário Barão de Mauá), E. Minóla(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), C Ferrara(Presidio Ospedaliero), Martina Felder(Ospedale di Bolzano)
Cited by 0
Related Papers
ChatGPT and the rise of large language models: the new AI-driven infodemic threat in public health
|Frontiers in Public Health|2023|640
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Close Encounters in a Pediatric Ward: Measuring Face-to-Face Proximity and Mixing Patterns with Wearable Sensors
|PLoS ONE|2011|269